Early qualitative risk assessment of the emerging zoonotic potential of animal diseases

British Medical Journal

Volumn 331, Issue 7527, 2005, Pages 1256-1260

  Palmer, Stephen ^a   Brown, David ^b   Morgan, Dilys ^b  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CARE; ANIMAL DISEASE; BORNA DISEASE; BORNA DISEASE VIRUS; CIRCOVIRIDAE; CLINICAL FEATURE; CLOSTRIDIUM DIFFICILE; CROSS INFECTION; DISEASE MARKER; EARLY DIAGNOSIS; EVIDENCE BASED MEDICINE; HEPATITIS E; HUMAN; INFECTION RISK; MEDICAL EXPERT; MEDICAL INFORMATION; NOROVIRUS; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; ZOONOSIS;

EID: 28244500017     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.331.7527.1256     Document Type: Review

References (23)

1. Taylor LH, Latham SM, Woolhouse ME. Risk factors for human disease emergence. Philos Trans R Soc Lond B Biol Sci 2001;356:983-9.
2. Lanska DJ. The mad cow problem in the UK: risk perceptions, risk management, and health policy development. J Public Health Policy 1998;19:160-83.
3. Cash RA, Narasimhan V. Impediments to global surveillance of infectious diseases: consequences of open reporting in a global economy. Bull World Health Organ 2000;78:1358-67.
4. Strategy Unit, Cabinet Office. Risk: improving government's capability to handle risk and uncertainty. London: Strategy Unit, 2002 (www.strategy.gov.uk/ downloads/su/risk/risk/report/report/downloads/su-risk.pdf).
5. Morgan D. The Human Animal Infections and Risk Surveillance group (poster No 33). In: Proceedings of the 2nd International Conference on the Prevention and Control of Zoonoses, from Science to Policy. 2005 Jun 15-17; In: Liverpool, UK. www.hpazoonosesconference.org.uk/PrevCtrlZoon05_posters.pdf (accessed 14 Nov 2005).
6. Meng X-J. Zoonotic and xenozoonotic risks of the hepatitis E virus. Infect Dis Rev 2000;2:35-41.
7. Ijaz S, Arnold E, Banks M, Bendall RP, Cramp ME, Cunningham R, et al. Non-travel-associated hepatitis e in England and Wales: demographic, clinical, and molecular epidemiological characteristics. J Infect Dis 2005;192:1166-72. (Epub 2005 Aug 22.)
8. Chae C. A review of porcine circovirus 2-associated syndromes and diseases. Vet J 2005;169:326-36.
9. Ellis JA, Wiseman BM, Allan G, Konoby C, Krakowka S, Meehan BM, et al. Analysis of seroconversion to porcine circovirus 2 among veterinarians from the United States and Canada. J Am Vet Med Assoc 2000;217:1645-6.
10. Oliver SL, Dastjerdi AM, Wong S, El-Attar L, Gallimore C, Brown DW, et al. Molecular characterization of bovine enteric caliciviruses: a distinct third genogroup of noroviruses (Norwalk-like viruses) unlikely to be of risk to humans J Virol 2003;77:2789-98.
11. Smiley JR, Hoet AE, Traven M, Tsunemitsu H, Saif LJ. Reverse transcription-PCR assays for detection of bovine enteric caliciviruses (BEC) and analysis of the genetic relationships among BEC and human caliciviruses. J Clin Microbiol 2003;41:3089-99.
12. Cotto E, Neau D, Cransac-Neau M, Auriacombe M, Pellegrin JL, Ragnaud JM, et al. Borna disease virus RNA in immunocompromised patients in southwestern France. J Clin Microbiol 2003;41:5577-81.
13. Chalmers RM, Thomas DR, Salmon RL. Borna disease virus and the evidence for human pathogenicity: a systematic review. Q J Med 2005;98:255-74.
14. Davidson F, Lycett C, Petrik J, Fazakerley JK. Investigation of frequency of active Borna disease virus infection in Scottish blood donors. Vox Sang 2004;86:148-50.
15. Poxton PR. Clostridium difficile. J Med Microbiol 2005;54:97-100.
16. World Health Organization. Xenotransplantation: guidance on infectious disease prevention and management. In: Emerging and other communicable diseases surveillance and control. Geneva: WHO, 1998. (WHO/EMC/200/98.1.)
17. Boneva RS, Folks TM. Xenotransplantation and risks of zoonotic infection. Ann Med 2004;36:504-17.
18. Audelo-del-Valle J, Clement-Mellado O, Magana-Hernandez A, Flisser A, Montiel-Aguirre F, Briseno-Garcia B. Infection of cultured human and monkey cell lines with extract of penaeid shrimp infected with Taura syndrome virus. Emerg Infect Dis 2003;9:265-6.
19. Pantoja CR, Navarro SA, NaranjoJ, Lightner DV, Gerba CP. Nonsusceptibility of primate cells to Taura syndrome virus. Emerg Infect Dis 2004;10:2106-12.
20. Cook N, Bridger J, Kendall K, Gomara MT, El-Attar L, Gray J. The zoonotic potential of rotavirus. J Infect 2004;48:289-302.
21. Scientific Committee on Animal Health and Animal Welfare. Assessment of wonotic risk from infectious salmon anaemia virus. Brussels: European Commission Health and Consumer Protection Directorate-General, 2000. (http://europa.eu. int/comm/food/fs/sc/scah/out44_en.pdf).
22. Brown KE, Liu Z, Gallinella G, Wong S, Mills IP, O'Sullivan MG. Simian parvovirus infection: a potential zoonosis. J Infect Dis 2004;190:1900-7.
23. Thomas DR, Salmon RL, Coleman TJ, Morgan-Capner P, Sillis M, Caul EO, et al. Occupational exposure to animals and risk of zoonotic illness in a cohort of farmers, farm workers and their families in England. J Agric Saf Health 1999;5:373-82.